The Effectiveness of Deflux® Treatment for Vesicoureteral Reflux Following Pediatric Renal Transplantation: A Single-Institution Challenging Experience

This single-center study evaluates Deflux® (dextranomer/hyaluronic acid) endoscopic injection as a minimally invasive treatment for vesicoureteral reflux occurring after pediatric kidney transplantation. The research addresses a challenging post-transplant complication where traditional surgical approaches carry higher risk in immunosuppressed patients.